| Download the amazing global Makindo app: ✅ Means NICE/National Guidelines 2026 compliant Android | Apple | |
|---|---|
| MEDICAL DISCLAIMER: Educational use only. Not for diagnosis or management. See below for full disclaimer. |
🍽️ Gastrointestinal anatomy, physiology and pharmacology — the gut digests food, absorbs nutrients and water, and gets rid of waste; the liver processes almost everything absorbed, including most drugs. Knowing the blood supply, the portal circulation, where things are absorbed and what the liver does explains most GI symptoms, blood tests and complications. Most GI drugs reduce acid, stop vomiting, change bowel movement, calm gut inflammation or treat liver disease.
Your four questions for every drug: How does it work? What is it used for? What are the important side effects and safety issues? What does it interact with, and how is it monitored?
| Gut region | Artery (aortic level) | Supplies | Pain felt |
|---|---|---|---|
| Foregut | Coeliac trunk (T12) | Lower oesophagus to the 2nd part of the duodenum (ampulla), liver, gallbladder, pancreas (part), spleen | Epigastrium |
| Midgut | Superior mesenteric artery (L1) | Ampulla to two-thirds of the way along the transverse colon (small bowel, caecum, appendix, ascending colon) | Around the umbilicus |
| Hindgut | Inferior mesenteric artery (L3) | Distal transverse colon to the upper anal canal | Suprapubic |
| Nutrient | Where absorbed | Key points |
|---|---|---|
| Iron | Duodenum and upper jejunum | Absorbed as ferrous (Fe2+) iron — helped by acid and vitamin C, reduced by PPIs, tea and calcium. Controlled by hepcidin (made by the liver — blocks iron release from gut cells); inflammation raises hepcidin (anaemia of chronic disease). Oral iron raises hepcidin for about a day, so alternate-day dosing can improve absorption and tolerance. |
| Vitamin B12 | Terminal ileum | Released from food by acid, bound to intrinsic factor (from parietal cells), absorbed in the terminal ileum. Body stores last 3–5 years. Deficiency — pernicious anaemia, gastrectomy, ileal disease or resection, bacterial overgrowth, metformin, long-term PPIs, vegan diet. |
| Folate | Jejunum | Stores last only about 4 months. Deficiency — poor diet, alcohol, coeliac disease, pregnancy, haemolysis, drugs (methotrexate, trimethoprim, phenytoin, sulfasalazine). |
| Calcium | Duodenum (active, needs vitamin D) | Reduced in coeliac disease, vitamin D deficiency, fat malabsorption. |
| Fat-soluble vitamins (A, D, E, K) | Small bowel, with fat | Lost in fat malabsorption; vitamin K deficiency raises INR (corrects with IV vitamin K if cholestatic, not if the liver can't make clotting factors). |
| Bile acids | Terminal ileum | Loss causes bile acid diarrhoea and, if large, fat malabsorption. |
| Thiamine (B1) | Jejunum | Low stores (weeks); deficient in alcohol excess, vomiting, malnutrition — Wernicke's encephalopathy; give before glucose in at-risk patients. |
| Hormone | Made by | Main actions | Clinical link |
|---|---|---|---|
| Gastrin | G cells (antrum) | Stimulates acid; growth of the stomach lining | Gastrinoma; high on PPIs and in atrophic gastritis |
| CCK | I cells (duodenum, jejunum) | Gallbladder contraction; pancreatic enzymes; satiety | Pain after fatty meals in gallstones |
| Secretin | S cells (duodenum) | Pancreatic bicarbonate; reduces acid | Secretin-enhanced MRCP |
| Somatostatin | D cells (stomach, pancreas) | Inhibits most gut hormones and secretions | Octreotide — varices (some use), NETs, high-output stomas |
| Motilin | Small bowel | Migrating motor complex | Erythromycin mimics it |
| GLP-1 and GIP | L cells and K cells | Insulin release, slower gastric emptying, satiety | Semaglutide, tirzepatide |
| Ghrelin | Stomach | Hunger | Falls after sleeve gastrectomy |
| VIP | Enteric neurons | Relaxes smooth muscle; secretion | VIPoma — watery diarrhoea, low potassium |
| Serotonin (5-HT) | Enterochromaffin cells (most of the body's 5-HT) | Motility, secretion, nausea | Carcinoid syndrome; ondansetron; prucalopride |
| Test | Typical adult range | What it shows |
|---|---|---|
| Bilirubin | Under 21 micromol/L | Excretion; visible jaundice usually over about 40–50 |
| ALT | Under about 40 U/L (varies) | Liver cell damage (hepatocellular) |
| AST | Under about 40 U/L | Liver, muscle, heart, red cells; AST:ALT over 2 suggests alcohol |
| ALP | About 30–130 U/L | Bile ducts (cholestasis), bone, placenta, growing children |
| GGT | Under about 50 U/L | Confirms a liver source of ALP; raised by alcohol and enzyme-inducing drugs |
| Albumin | 35–50 g/L | Chronic synthetic function (also nutrition, inflammation, losses) |
| Prothrombin time / INR | INR about 0.8–1.2 | Acute synthetic function (and vitamin K status) |
| Platelets | 150–400 × 10⁹/L | Low in portal hypertension (splenic pooling) |
| Amylase / lipase | Lab-specific | Over 3 times the upper limit supports acute pancreatitis |
| Faecal calprotectin | Under about 50 micrograms/g | Gut inflammation — helps separate IBD from IBS |
| Ascitic neutrophils | Under 250 cells/mm³ | Over 250 — spontaneous bacterial peritonitis |
| Drug | Receptor | Best for | Key cautions |
|---|---|---|---|
| Metoclopramide | D2 antagonist (also speeds gastric emptying) | Gastric stasis, migraine, post-operative, drug-induced | Extrapyramidal effects — acute dystonia (young women), tardive dyskinesia; maximum 5 days, 10 mg up to 3 times a day (MHRA); avoid in Parkinson's, bowel obstruction, under 1 year |
| Domperidone | Peripheral D2 antagonist (doesn't cross the blood–brain barrier) | Nausea in Parkinson's (e.g. with dopaminergic drugs), gastroparesis | QT prolongation and sudden cardiac death — lowest dose, shortest time (usually up to 7 days), avoid with QT-prolonging drugs and CYP3A4 inhibitors and in cardiac disease (MHRA) |
| Ondansetron | 5-HT3 antagonist | Chemotherapy, radiotherapy, post-operative, gastroenteritis | Constipation, headache, QT prolongation; small increased risk of oral clefts if used in the first trimester (MHRA) — not first-line in pregnancy |
| Cyclizine | H1 antihistamine (and antimuscarinic) | Motion sickness, vertigo, bowel obstruction, raised intracranial pressure, pregnancy | Drowsiness, dry mouth; can worsen heart failure; misuse potential (IV) |
| Prochlorperazine | D2 antagonist (phenothiazine) | Vertigo, labyrinthitis, migraine, pregnancy | Extrapyramidal effects, drowsiness, postural hypotension; avoid in Parkinson's |
| Haloperidol (low dose) | D2 antagonist | Chemical causes (drugs, renal failure, high calcium) — palliative care | Extrapyramidal effects, QT; avoid in Parkinson's and Lewy body dementia |
| Levomepromazine | Broad (D2, 5-HT2, H1, alpha) | Palliative care when others fail | Sedation, hypotension |
| Hyoscine (hydrobromide patch or butylbromide) | Antimuscarinic | Motion sickness (hydrobromide); colic and secretions in bowel obstruction (butylbromide) | Dry mouth, confusion in older people (hydrobromide), urinary retention, glaucoma |
| Aprepitant | NK1 antagonist | Chemotherapy (with ondansetron and dexamethasone) | CYP3A4 interactions (reduces the effect of the pill and warfarin) |
| Dexamethasone | Corticosteroid | Chemotherapy; raised intracranial pressure; palliative care | Hyperglycaemia, insomnia (give in the morning) |
| Type | Examples | How they work | Key points |
|---|---|---|---|
| Bulk-forming | Ispaghula husk, methylcellulose, sterculia | Hold water in stool; increase bulk | Need plenty of fluid; take days to work; avoid in opioid constipation and obstruction; bloating |
| Osmotic | Macrogol (polyethylene glycol), lactulose, magnesium salts, phosphate enemas | Hold water in the bowel | Macrogol — first-line in many; faecal impaction (high dose). Lactulose — bloating and wind; used in hepatic encephalopathy. Magnesium — avoid in CKD |
| Stimulant | Senna, bisacodyl, sodium picosulfate, glycerol suppositories | Increase gut movement and secretion | Cramps; work in 6–12 hours (orally); avoid in obstruction; add to macrogol for opioid constipation |
| Softeners | Docusate, arachis oil enema | Soften stool (docusate is also a weak stimulant) | Arachis oil contains peanut oil — avoid in peanut allergy |
| Opioid receptor antagonists (peripheral) | Naloxegol, methylnaltrexone, naldemedine | Block gut opioid receptors without reversing pain relief | For opioid-induced constipation not responding to laxatives; avoid in obstruction |
| Prokinetic / secretagogue | Prucalopride (5-HT4 agonist), linaclotide | Increase colonic movement or fluid secretion | Chronic constipation and IBS with constipation not helped by other laxatives (specialist or after 6–12 months) |
| Drug | Target | Key points |
|---|---|---|
| Infliximab (IV), adalimumab (SC), golimumab (UC) | TNF-alpha | Moderate to severe Crohn's and UC, perianal fistulas; TB reactivation, serious infections, worsens heart failure, demyelination, drug-induced lupus, paradoxical psoriasis, lymphoma (especially with thiopurines); infusion reactions; antibody formation — check drug levels and antibodies |
| Vedolizumab | Alpha-4 beta-7 integrin (blocks white cells entering the gut only) | Gut-selective — fewer systemic infections; slower onset; useful in older people and those with infection risk |
| Ustekinumab; risankizumab, mirikizumab, guselkumab | IL-12/23; IL-23 | Crohn's and UC; generally well tolerated; IV induction then SC maintenance |
| Tofacitinib, upadacitinib, filgotinib | JAK inhibitors (oral) | Fast acting; MHRA — increased risk of VTE, major cardiovascular events, cancer and serious infection: avoid in people over 65, smokers and those with cardiovascular or cancer risk unless no alternative; shingles (vaccinate); raised lipids; teratogenic |
| Ozanimod, etrasimod | S1P receptor modulators (oral — keep lymphocytes in lymph nodes) | UC; bradycardia on starting (ECG), macular oedema (eye checks), raised LFTs, infections; teratogenic |
| Pattern | Typical drugs |
|---|---|
| Hepatocellular (ALT up) | Paracetamol (overdose), isoniazid, rifampicin, pyrazinamide, valproate, methotrexate, statins (usually mild), amiodarone, nitrofurantoin, ketoconazole, NSAIDs (diclofenac), herbal supplements (green tea extract, kava, turmeric), checkpoint inhibitors |
| Cholestatic (ALP up) | Co-amoxiclav (may start up to 6 weeks after the course), flucloxacillin (older people; may be delayed), chlorpromazine, combined pill, anabolic steroids, carbimazole, sulfonylureas, erythromycin, terbinafine |
| Fatty liver | Amiodarone, methotrexate, steroids, tamoxifen, valproate (microvesicular), tetracyclines (IV) |
| Fibrosis and cirrhosis | Methotrexate (long term), amiodarone, vitamin A excess |
| Autoimmune-like hepatitis | Nitrofurantoin, minocycline, methyldopa, anti-TNF drugs |
| Vascular (sinusoidal obstruction) | Chemotherapy (oxaliplatin), azathioprine, herbal pyrrolizidine alkaloids |
| Liver tumours | Combined pill and anabolic steroids (adenomas) |
| Problem | Typical drugs |
|---|---|
| Peptic ulcer and GI bleeding | NSAIDs, aspirin, anticoagulants, clopidogrel, SSRIs (with NSAIDs), steroids (with NSAIDs), bisphosphonates, potassium tablets — combinations multiply the risk |
| Pill oesophagitis | Doxycycline, bisphosphonates, potassium chloride, iron, NSAIDs |
| Constipation | Opioids, anticholinergics (oxybutynin, TCAs), iron, calcium, aluminium antacids, verapamil, ondansetron, clozapine (can cause fatal bowel obstruction — MHRA) |
| Diarrhoea | Antibiotics (and C. difficile), metformin, magnesium, colchicine (also an early sign of toxicity), mycophenolate, PPIs, SSRIs, laxative misuse, checkpoint inhibitors (colitis) |
| C. difficile risk | Clindamycin, cephalosporins, co-amoxiclav, quinolones; PPIs |
| Microscopic colitis | NSAIDs, PPIs (lansoprazole), SSRIs, statins |
| Nausea and vomiting | Opioids, digoxin toxicity, theophylline, chemotherapy, antibiotics, GLP-1 agonists, iron, metformin |
| Pancreatitis | Azathioprine, mesalazine, valproate, thiazides and furosemide, GLP-1 agonists and gliptins, steroids, oestrogens (via triglycerides), some HIV drugs |
| Gastroparesis / slow emptying | Opioids, GLP-1 agonists, tirzepatide, anticholinergics |
| Gingival overgrowth and dry mouth | Phenytoin, ciclosporin, calcium channel blockers (overgrowth); anticholinergics (dry mouth) |
| Hepatic encephalopathy | Sedatives, opioids, diuretics (low potassium and sodium), constipation |
| Drug | Key points |
|---|---|
| Omeprazole / lansoprazole (PPIs) | Before breakfast; C. difficile, low magnesium, fractures, B12; omeprazole reduces clopidogrel activation; stop 2 weeks before H. pylori testing. |
| Famotidine (H2 blocker) | Weaker than PPIs; ranitidine withdrawn. |
| Alginates / antacids | Sodium load; separate from other drugs by 2 hours. |
| Misoprostol | Protects stomach lining; diarrhoea; contraindicated in pregnancy. |
| H. pylori triple therapy | PPI + amoxicillin + clarithromycin or metronidazole for 7 days; metronidazole and alcohol react. |
| Metoclopramide | D2 antagonist and prokinetic; dystonia; maximum 5 days; avoid in Parkinson's and obstruction. |
| Domperidone | Safe in Parkinson's; QT and cardiac risk. |
| Ondansetron | 5-HT3 antagonist; constipation, QT; small cleft risk in first trimester. |
| Cyclizine | H1 antihistamine; vertigo, obstruction; avoid in heart failure. |
| Macrogol / senna / ispaghula | Osmotic / stimulant / bulk; no bulk-forming for opioid constipation. |
| Lactulose | Osmotic; hepatic encephalopathy — 2–3 soft stools a day. |
| Naloxegol | Peripheral opioid antagonist for opioid constipation. |
| Loperamide | Avoid in bloody diarrhoea, C. difficile, IBD flares; arrhythmias in overdose. |
| Colestyramine | Bile acid diarrhoea and cholestatic itch; binds other drugs. |
| Mebeverine / hyoscine butylbromide | IBS antispasmodics; Buscopan injection — caution in heart disease. |
| Mesalazine / sulfasalazine | UC; interstitial nephritis (U&E), blood disorders; sulfasalazine — low sperm count, orange urine. |
| Prednisolone / IV hydrocortisone / budesonide | IBD flares only; 100 mg hydrocortisone QDS for acute severe UC; budesonide — high first-pass. |
| Azathioprine / mercaptopurine | Check TPMT; marrow suppression, pancreatitis, skin cancer; avoid allopurinol. |
| Methotrexate | Weekly; folic acid; teratogenic; avoid trimethoprim. |
| Infliximab / adalimumab | Anti-TNF; screen TB and hepatitis B; no live vaccines; avoid in heart failure. |
| Vedolizumab / ustekinumab | Gut-selective integrin / IL-12/23 blockade. |
| Tofacitinib / upadacitinib | JAK inhibitors; VTE, cardiovascular and cancer risk (MHRA); shingles. |
| Rifaximin | With lactulose to prevent recurrent hepatic encephalopathy. |
| Carvedilol / propranolol | Lower portal pressure; prevent variceal bleeding; hold if hypotensive or AKI. |
| Terlipressin | Variceal bleed and hepatorenal syndrome; ischaemia, hyponatraemia, respiratory failure (MHRA). |
| Spironolactone | First-line for ascites; hyperkalaemia, gynaecomastia. |
| Human albumin solution 20% | After paracentesis over 5 L (8 g per litre), SBP, hepatorenal syndrome. |
| Ursodeoxycholic acid | First-line for primary biliary cholangitis. |
| Pabrinex (thiamine) | Wernicke's prevention and treatment; before glucose. |
| Chlordiazepoxide / lorazepam | Alcohol withdrawal; lorazepam or oxazepam in liver impairment. |
| Acamprosate / naltrexone / disulfiram | Relapse prevention; naltrexone — not with opioids; disulfiram — reaction with any alcohol. |
| Pancreatin (Creon) | With every meal and snack; pork-derived. |
| Acetylcysteine | Paracetamol overdose — replenishes glutathione; UK nomogram line 100 mg/L at 4 hours. |
| Oral vancomycin / fidaxomicin | C. difficile infection. |
| Clue | Answer |
|---|---|
| Massive bleed from a posterior duodenal ulcer | Gastroduodenal artery erosion |
| Older patient with AF, severe abdominal pain, soft abdomen and high lactate | Acute mesenteric ischaemia (SMA embolus) |
| Left-sided pain and bloody diarrhoea after a hypotensive episode | Ischaemic colitis at the splenic flexure (watershed) |
| Painless bright red bleeding with a lump above the dentate line | Internal haemorrhoids (visceral innervation) |
| Painless jaundice and a palpable gallbladder | Pancreatic head cancer (Courvoisier's law) |
| B12 deficiency after a terminal ileal resection for Crohn's | Loss of the B12 absorption site |
| Watery diarrhoea after ileal resection, relieved by colestyramine | Bile acid diarrhoea |
| Diarrhoea that stops completely on fasting | Osmotic diarrhoea |
| Vomiting with low chloride, low potassium and high bicarbonate | Metabolic alkalosis from gastric losses |
| Low B12 with high folate and bloating after bowel surgery | Small intestinal bacterial overgrowth |
| Bilirubin 45 (unconjugated), normal LFTs, worse when fasting | Gilbert's syndrome |
| Dark urine, pale stools and itch | Obstructive (post-hepatic) jaundice |
| Raised ALP with normal GGT in an older man with bone pain | Bone source — Paget's or metastases |
| SAAG 15 g/L | Portal hypertension (e.g. cirrhosis) |
| Ascitic neutrophils 400 cells/mm³ in a confused cirrhotic | Spontaneous bacterial peritonitis — antibiotics and albumin |
| Recurrent stent thrombosis in a patient on clopidogrel and omeprazole | CYP2C19 interaction — switch to lansoprazole or pantoprazole |
| Low magnesium and hypocalcaemia on long-term PPI | PPI-induced hypomagnesaemia |
| Young woman with neck twisting and eyes rolling up after an antiemetic | Metoclopramide dystonia — procyclidine |
| Vomiting in a patient with Parkinson's disease | Domperidone (doesn't cross the blood–brain barrier) |
| Pancytopenia when allopurinol is added to azathioprine | Xanthine oxidase interaction — thiopurine toxicity |
| TB reactivation after starting a drug for Crohn's | Anti-TNF therapy (should have been screened) |
| Cholestatic jaundice 4 weeks after a course of co-amoxiclav | Drug-induced cholestasis (can be delayed) |
| Confused cirrhotic patient after codeine and constipation | Hepatic encephalopathy — lactulose, stop codeine |
| Flushing and vomiting after a drink on H. pylori treatment | Metronidazole disulfiram-like reaction |
1. A 58-year-old man with alcohol-related cirrhosis vomits 500 mL of fresh blood. HR 118, BP 92/58, Hb 78.
Answer: Suspected acute variceal bleeding.
2. A 68-year-old woman with a recent coronary stent takes aspirin, clopidogrel, omeprazole and ibuprofen for knee pain. She is admitted with melaena.
Answer: Upper GI bleed from NSAID-related ulceration, with a CYP2C19 interaction risk.
3. A 34-year-old man with Crohn's disease starts azathioprine. Six weeks later he has a sore throat and fever. He also takes allopurinol for gout, started by his GP last month.
Answer: Likely thiopurine-induced marrow suppression (neutropenic sepsis), worsened by allopurinol.
4. A 22-year-old woman is given IV metoclopramide for vomiting. An hour later her eyes deviate upwards and her neck twists to one side.
Answer: Acute dystonic reaction (oculogyric crisis).
5. A 65-year-old man with cirrhosis and ascites becomes drowsy and confused 3 days after admission. He has been given codeine for back pain and has not opened his bowels. He has a flapping tremor.
Answer: Hepatic encephalopathy precipitated by opioid and constipation.